相似文献
1
Patterns of care and clinical outcomes of patients with newly diagnosed acute myeloid leukemia presenting with hyperleukocytosis who do not receive intensive chemotherapy.
Leuk Lymphoma. 2020 May;61(5):1220-1225. doi: 10.1080/10428194.2020.1728753. Epub 2020 Feb 26.
2
Clinical characteristics and outcomes of children with newly diagnosed acute myeloid leukemia and hyperleukocytosis managed with different cytoreductive methods.
Cancer. 2023 Jun 15;129(12):1873-1884. doi: 10.1002/cncr.34751. Epub 2023 Mar 21.
3
The effect of therapeutic leukapheresis on early complications and outcomes in patients with acute leukemia and hyperleukocytosis: a propensity score-matched study.
Transfusion. 2018 Jan;58(1):208-216. doi: 10.1111/trf.14329. Epub 2017 Sep 28.
4
Impact of pre-induction therapy leukapheresis on treatment outcome in adult acute myelogenous leukemia presenting with hyperleukocytosis.
Ann Hematol. 2000 Sep;79(9):501-6. doi: 10.1007/s002770000162.
5
Impact of leukapheresis on early death rate in adult acute myeloid leukemia presenting with hyperleukocytosis.
Transfusion. 2007 Oct;47(10):1843-50. doi: 10.1111/j.1537-2995.2007.01406.x.
6
Hyperleukocytosis in Acute Myeloid Leukemia: Considerations for Inpatient Diagnosis and Management.
Clin J Oncol Nurs. 2023 Nov 16;27(6):589-593. doi: 10.1188/23.CJON.589-593.
7
Minimally early morbidity in children with acute myeloid leukemia and hyperleukocytosis treated with prompt chemotherapy without leukapheresis.
J Formos Med Assoc. 2014 Nov;113(11):833-8. doi: 10.1016/j.jfma.2014.01.006. Epub 2014 Feb 15.
8
Hyperleukocytosis and leukostasis in acute and chronic leukemias.
Leuk Lymphoma. 2022 Aug;63(8):1780-1791. doi: 10.1080/10428194.2022.2056178. Epub 2022 Mar 31.
9
Leukapheresis in patients newly diagnosed with acute myeloid leukemia.
Transfus Apher Sci. 2016 Oct;55(2):216-220. doi: 10.1016/j.transci.2016.07.001. Epub 2016 Jul 14.
10
A diagnostic dilemma in the emergency room: intracranial hemorrhages in acute myeloblastic leukemia with hyperleukocytosis.
Acta Neurol Belg. 2020 Apr;120(2):487-489. doi: 10.1007/s13760-018-0925-9. Epub 2018 Apr 23.
引用本文的文献
1
[Analysis of risk factors for early death in hyperleukocytic acute leukemia].
Zhonghua Xue Ye Xue Za Zhi. 2025 Jan 14;46(1):53-57. doi: 10.3760/cma.j.cn121090-20240917-00351.
2
Complete elimination of hyperleukocytosis risk in AML through early high-quality disease remission.
Front Oncol. 2024 Jun 13;14:1412583. doi: 10.3389/fonc.2024.1412583. eCollection 2024.
3
Leukapheresis Does Not Improve Early Survival Outcome of Acute Myeloid Leukemia with Leukostasis Patients - A Dual-Center Retrospective Cohort Study.
J Blood Med. 2021 Jul 14;12:623-633. doi: 10.2147/JBM.S312140. eCollection 2021.
4
Hyperleukocytosis and Leukostasis in Acute Myeloid Leukemia: Can a Better Understanding of the Underlying Molecular Pathophysiology Lead to Novel Treatments?
Cells. 2020 Oct 17;9(10):2310. doi: 10.3390/cells9102310.
5
Leukapheresis for the management of hyperleukocytosis in acute myeloid leukemia-A systematic review and meta-analysis.
Transfusion. 2020 Oct;60(10):2360-2369. doi: 10.1111/trf.15994. Epub 2020 Aug 10.
本文引用的文献
1
Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retrospective, multicenter, international study.
Leukemia. 2020 Dec;34(12):3149-3160. doi: 10.1038/s41375-020-0783-3. Epub 2020 Mar 4.
2
The golden age for patients in their golden years: The progressive upheaval of age and the treatment of newly-diagnosed acute myeloid leukemia.
Blood Rev. 2020 Mar;40:100639. doi: 10.1016/j.blre.2019.100639. Epub 2019 Nov 8.
3
Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges.
Blood Rev. 2019 Jul;36:70-87. doi: 10.1016/j.blre.2019.04.005. Epub 2019 Apr 29.
4
Utilization of initial chemotherapy for newly diagnosed acute myeloid leukemia in the United States.
Blood Adv. 2018 Jun 12;2(11):1277-1282. doi: 10.1182/bloodadvances.2018019125.
5
The effect of therapeutic leukapheresis on early complications and outcomes in patients with acute leukemia and hyperleukocytosis: a propensity score-matched study.
Transfusion. 2018 Jan;58(1):208-216. doi: 10.1111/trf.14329. Epub 2017 Sep 28.
6
Leukapheresis reduces 4-week mortality in acute myeloid leukemia patients with hyperleukocytosis - a retrospective study from a tertiary center.
Leuk Lymphoma. 2017 Sep;58(9):1-11. doi: 10.1080/10428194.2016.1277386. Epub 2017 Jan 31.
7
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.
Blood. 2017 Jan 26;129(4):424-447. doi: 10.1182/blood-2016-08-733196. Epub 2016 Nov 28.
8
How I treat hyperleukocytosis in acute myeloid leukemia.
Blood. 2015 May 21;125(21):3246-52. doi: 10.1182/blood-2014-10-551507. Epub 2015 Mar 16.
9
Hyperleukocytosis, leukostasis and leukapheresis: practice management.
Blood Rev. 2012 May;26(3):117-22. doi: 10.1016/j.blre.2012.01.003. Epub 2012 Feb 23.
10
Practical considerations for planning a therapeutic apheresis procedure.
Am J Med. 2010 Sep;123(9):777-84. doi: 10.1016/j.amjmed.2010.01.022. Epub 2010 Jun 11.
Zotero 插件